Feasibility of ![]() |
Yoon, Soon-Ho
(Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center)
Park, Chang-Min (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center) Lee, Chang-Hyun (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center) Song, In-Chan (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center) Lee, Hyun-Ju (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center) Goo, Jin-Mo (Department of Radiology, Seoul National University College of Medicine, Institute of Radiation Medicine, Seoul National University Medical Research Center) |
1 | Hanaoka H, Yoshioka Y, Ito I, Niitu K, Yasuda N. In vitro characterization of lung cancers by the use of 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis. Magn Reson Med 1993;29:436-440 |
2 | Yokota H, Guo J, Matoba M, Higashi K, Tonami H, Nagao Y. Lactate, choline, and creatine levels measured by vitro 1H-MRS as prognostic parameters in patients with non-small-cell lung cancer. J Magn Reson Imaging 2007;25:992-999 |
3 | Duarte IF, Rocha CM, Barros AS, et al. Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumours? Virchows Arch 2010;457:715-725 |
4 | Rocha CM, Barros AS, Gil AM, et al. Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J Proteome Res 2010;9:319-332 |
5 | Christiansen P, Henriksen O, Stubgaard M, Gideon P, Larsson HB. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging 1993;11:107-118 |
6 | Stanwell P, Mountford C. In vivo proton MR spectroscopy of the breast. Radiographics 2007;27 Suppl 1:S253-S266 |
7 | Qayyum A. MR spectroscopy of the liver: principles and clinical applications. Radiographics 2009;29:1653-1664 |
8 | Opstad KS, Wright AJ, Bell BA, Griffiths JR, Howe FA. Correlations between in vivo (1)H MRS and ex vivo (1)H HRMAS metabolite measurements in adult human gliomas. J Magn Reson Imaging 2010;31:289-297 |
9 | Seppenwoolde Y, Shirato H, Kitamura K, et al. Precise and realtime measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys 2002;53:822-834 |
10 | Guo J, Higashi K, Yokota H, et al. In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18FFDG uptake, and prognosis in patients with lung adenocarcinoma. J Nucl Med 2004;45:1334-1339 |
11 | Smith JK, Kwock L, Castillo M. Effects of contrast material on single-volume proton MR spectroscopy. AJNR Am J Neuroradiol 2000;21:1084-1089 |
12 | Dydak U, Schar M. MR spectroscopy and spectroscopic imaging: comparing 3.0 T versus 1.5 T. Neuroimaging Clin N Am 2006;16:269-283 |
13 | Gabr RE, Sathyanarayana S, Schar M, Weiss RG, Bottomley PA. On restoring motion-induced signal loss in single-voxel magnetic resonance spectra. Magn Reson Med 2006;56:754-760 |
14 | Weiss E, Wijesooriya K, Dill SV, Keall PJ. Tumor and normal tissue motion in the thorax during respiration: analysis of volumetric and positional variations using 4D CT. Int J Radiat Oncol Biol Phys 2007;67:296-307 |
15 | Chen W, Zu Y, Huang Q, et al. Study on metabonomic characteristics of human lung cancer using high resolution magic-angle spinning 1H NMR spectroscopy and multivariate data analysis. Magn Reson Med 2011;66:1531-1540 |
16 | Kuo YT, Li CW, Chen CY, Jao J, Wu DK, Liu GC. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 2004;19:598-604 |
17 | Gold GE, Pauly JM, Leung AN, et al. Short echo time MR spectroscopic imaging of the lung parenchyma. J Magn Reson Imaging 2002;15:679-684 |
18 | Golder W. Magnetic resonance spectroscopy in clinical oncology. Onkologie 2004;27:304-309 |
19 | Brescia FJ. Lung cancer--a philosophical, ethical, and personal perspective. Crit Rev Oncol Hematol 2001;40:139-148 |
20 | Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. The New England Journal of Medicine 2005;352:2714-2720 |
21 | Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223-232 |
22 | Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 1999;213:473-480 |
23 | Yeung DKW, Cheung HS, Tse GMK. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopyoInitial results. Radiology 2001;220:40-46 |
24 | Allen JR, Prost RW, Griffith OW, Erickson SJ, Erickson BA. In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma. Am J Clin Oncol 2001;24:522-529 |
![]() |